Breakdown | |||||
TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
36.32B | 36.61B | 44.55B | 41.71B | 31.52B | 37.29B | Gross Profit |
2.19B | 1.92B | 4.45B | 4.15B | 1.56B | 4.06B | EBIT |
-1.15B | -1.64B | 821.00M | 530.00M | -2.07B | -5.00M | EBITDA |
-125.50M | 9.29B | 2.02B | 1.82B | -4.45B | 1.83B | Net Income Common Stockholders |
-997.00M | 6.61B | -150.00M | 417.00M | -6.45B | -49.00M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
183.00M | 829.00M | 124.00M | 155.00M | 164.00M | 204.00M | Total Assets |
39.55B | 38.96B | 42.00B | 39.34B | 37.34B | 47.22B | Total Debt |
6.71B | 2.33B | 10.24B | 8.13B | 8.76B | 11.65B | Net Debt |
6.53B | 2.16B | 10.12B | 7.98B | 8.60B | 11.45B | Total Liabilities |
19.28B | 17.19B | 26.86B | 24.08B | 22.50B | 26.02B | Stockholders Equity |
20.28B | 21.77B | 15.13B | 15.26B | 14.84B | 21.20B |
Cash Flow | Free Cash Flow | ||||
0.00 | -3.05B | -1.47B | -161.00M | -222.00M | -1.45B | Operating Cash Flow |
0.00 | -2.33B | -985.00M | 481.00M | 1.01B | 1.74B | Investing Cash Flow |
0.00 | 10.58B | -354.00M | -567.00M | 2.41B | -3.04B | Financing Cash Flow |
0.00 | -8.15B | 1.90B | -676.00M | -2.76B | 1.30B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
76 Outperform | ¥3.13T | 8.54 | 6.77% | 5.02% | 1.42% | -27.64% | |
72 Outperform | $654.25B | 6.38 | 9.34% | 4.80% | -0.32% | -23.77% | |
70 Outperform | €234.49B | 4.41 | 6.56% | 4.92% | -0.91% | 80.48% | |
66 Neutral | $987.71B | 11.38 | 3.62% | 5.08% | -4.62% | -30.09% | |
49 Neutral | $1.96B | -1.15 | -21.28% | 3.71% | 1.17% | -30.86% | |
39 Underperform | ¥5.73B | ― | 12.79% | -5.41% | -114.91% |